Company Inno-Gene S.A.

Equities

IGN

PLINNGN00015

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sector Bio Diagnostics & Testing

End-of-day quote Warsaw S.E. Other stock markets 03:30:00 15/05/2024 am IST			5-day change	1st Jan Change
1.76 ^PLN	0.00%		-1.68%	-20.00%

14/02	Inno-Gene S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02	Inno-Gene S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Inno-Gene SA is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA's portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.

Number of employees: 10

PLN in Million	2021	Weight	2022	Weight	Delta
COVID Services 99.1 %	-	-	16	99.1 %	-
Other Services 0.5 %	-	-	0	0.5 %	-
Other Studies 0.4 %	-	-	0	0.4 %	-

PLN in Million	2021	Weight	2022	Weight	Delta
Poland 100.0 %	30	100.0 %	16	100.0 %	-44.98%

Managers	Title	Age	Since
Jacek Wojciechowicz CEO	Chief Executive Officer	-	01/10/01

Members of the board	Title	Age	Since
Dawid Marek Sukacz BRD	Director/Board Member	49	-
Krzysztof Królikowski CHM	Chairman	-	01/16/01
Marcin Golebicki BRD	Director/Board Member	-	-
Piotr Kinicki BRD	Director/Board Member	-	02/21/02
Jerzy Spindel BRD	Director/Board Member	-	02/21/02
Zbigniew Dembiecki BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	5,701,081	3,352,702 ( 58.81 %)	0	58.81 %

Inno Gene SA

ul. Sciegiennego 20

60-128, Poznan

+48 509 65 80 06

http://www.inno-gene.eu

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
INNO-GENE S.A.	-20.00%	2.79M
EXACT SCIENCES CORPORATION	-27.90%	9.84B
GUARDANT HEALTH, INC.	-4.81%	3.15B
IOVANCE BIOTHERAPEUTICS, INC.	+31.37%	2.99B
BGI GENOMICS CO., LTD.	-14.73%	2.15B
VERACYTE, INC.	-14.39%	1.8B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+70.99%	1.49B
CAREDX, INC	+23.17%	770M
SEEGENE, INC.	-2.18%	762M
CURIOX BIOSYSTEMS CO., LTD	+3.18%	308M

Bio Diagnostics & Testing